Established 1999
 
8,000 companies from
USA,Canada and India.
 
   
Search over 25,000 News & Earnings Archives    
 
Market Update : 
Telecoms Lift France, Drug Stocks Drag U.K.
Author: Elena Todorova
123jump.com
Last Update: 1:17 PM EDT October 26 2006


(Continued)

Email article | Print article

European stock markets closed mixed on Thursday, reflecting disappointing news from major drug companies, losses in the metals sector, and positive earnings news from other companies like Royal Dutch Shell and telecoms provider France Telecom. London FTSE 100 finished down 0.48%, dragged by AstraZeneca and GlaxoSmithCline. The German DAX 30 gained 0.31%. The French CAC 40 rose 0.21%.

 
The United Forum of Bank Unions, an umbrella of nine unions, has called a nationwide strike tomorrow to oppose outsourcing, privatisation and the proposed rise in voting rights of foreign investors in private banks.

The World Bank will consider an assistance of $5 billion (Rs 25,000 crore) to the state government for the development of the Mumbai Metropolitan Region over the next 10 years, announced Chief Minister Vilasrao Deshmukh after a meeting with World Bank officials today.


9:45AM Market opened higher on economic data and strong earnings.
U.S. stocks extended gains Thursday. The Dow Jones Industrial Average gained for a fourth day in a row, helped by strong results from Exxon Mobil and upbeat economic data. The Commerce Department reported capital spending continued to rise as durable goods orders jumped to a six-year high of 7.8%. Exxon Mobil (XOM: chart) rose 1.5% after the oil giant posted better-than-expected quarterly results, buoyed by higher crude-oil and natural-gas realizations and improved marketing. Meanwhile, Royal Dutch Shell reported a 34% drop in Q3 profit, as rising costs, higher taxes and reduced output from Nigeria weighed, but its result still beat analysts'' expectations. Navteq (NVT: chart) climbed 14% after reporting Q3 profit drop of 73% compared with a year-ago quarter bolstered by a tax gain. Quarterly earnings fell to $27.1 million, or 28 cents per share, from $101.1 million, or $1.07 per share last year.

Chico’s FAS (CHS: chart) rose nearly 5% after it was upgraded at Prudential to an Overweight rating. Starwood Hotels & Resorts Worldwide (HOT: chart) reported Q3 quadrupled to 71 cents a share from 17 cents last year, despite 2.3% lower revenue, beating estimates of 50 cents a share. Starwood expects to earn 73 cents a share in Q4. The stock slipped 3%. In other news, shares of Red Hat (RHAT: chart) plunged 23% after Oracle Corp. (ORCL: chart) said it would offer full technological support for Red Hat''s Linux operating system at a much lower price than Red Hat charges for its services. In early trading, the Dow rose 23.77, or 0.20%, to 12,158.45. The Dow reached a new trading high Thursday, 12,165.26. The Standard & Poor''s 500 index rose 4.06, or 0.29%, to 1,386.28, and the Nasdaq composite index added 8.61, or 0.37%, to 2,365.20.


9:30AM The FTSE 100 erases earlier gains Thursday as pharma stocks decline.
The FTSE 100 in London is almost flat in the afternoon, at 6,217, or 0.03% higher.

Decliners

AstraZeneca tumbled on news it has stopped the development of its experimental stroke drug NXY-059 as it failed to reduce significant disability in patients. The shares lost 7.48%.

GlaxoSmithKline also slipped despite raising earnings guidance for the year to mid-teens EPS growth from 12% previously, hiked its dividend and increased its share buyback program. The company shed 3.57%.

British American Tobacco also fell despite lifting nine month earnings by 13%, adding it is on track for a good year. Underlying profits rose 8% on revenues up 5%. The company stock declined 1.47%.

Cadbury Schweppes melted away as it said UK confectionery has been weaker than expected. Its shares moved back 1.10%. Medical product sterilisation firm Isotron has rejected an offer from Synergy Healthcare, saying it had no hesitation in doing so. Synergy Healthcare lost 5.04%. Discount retailer Instore has warned profits for the full year will be below expectations due to hefty stock clearance and restructuring measures. Its shares fell 10.17%.

Advancers

Third quarter results from Royal Dutch Shell were well received though as the oil titan reported a better than expected 33% increase in third quarter earnings per share before asset disposals. The company rose 3.91%.

Isotron has surged 7.17% after it rejected a bid offer. BP and BG rose, 0.57% and 0.08%, respectively. Vodafone meanwhile continues to rally from its recent lows. Vedanta Resources has gained 3.07%.

Other news

Independent News & Media, the media company, has launched a bid for APN News & Media, the Australian media group, valuing it at about 1.1billion pounds.


9:00AM Stock futures advanced on Exxon Mobil earnings and steady rates.
U.S. stock futures indicated a higher opening, with further gains expected on the back of stronger-than-expected earnings and steady interest rates. A bigger-than-expected jump in durable goods orders and higher weekly jobless claims had little effect on futures. U.S. durable goods orders soared 7.8% in September, as orders for new aircraft nearly tripled. This was the biggest jump in six years, above estimates of 2.8% increase. In another report, the Labor Department said that the number of newly laid-off workers filing claims for unemployment benefits rose by 8,000 to 308,000 last week.

Exxon Mobil (XOM: chart) advanced 1.6% in pre-market trading after posting better-than-expected Q3 results. The oil giant reported Q3 earnings rise of $10.49 billion, or $1.77 per share, up from a year-ago profit of $9.92 billion, or $1.58 per share, exceeding expectations of $1.59. Revenue slipped to $99.59 billion from $100.72 billion a year earlier. Exxon attributed the higher earnings to the impact of its continuing share purchase program, higher crude oil and natural gas realizations, and improved marketing.
  1  2  3  4

 




350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries

© 1999-2008 123jump.com. All rights reserved